GAITHERSBURG, Md., March 19, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has completed the sale of its Baltimore-Bayview drug substance manufacturing ...
Turning to Slide 2. During today's call, Emergent may make projections and other forward-looking statements related to their business, future events, their prospects, or future performance.
Analysts have recently evaluated Emergent BioSolutions and provided 12-month price targets. The average target is $15.0, ...
"The Riara Group of Schools was founded by Daniel and Professor Eddah Gachukia in 1974 as a commitment to the development of ...
Independent.ie on MSN1d
Lender to quit mortgage business as banks benefit from lower funding costsThe mortgage market has suffered a blow after non-bank lender said it will stop issuing residential home loans.
Seattle on the wrong side of dramatic final period and overtime, but valiant efforts from Jordan Eberle, Joey Daccord and ...
The National Interest on MSN8d
The U.S. Air Force Conducted a Live Weapons Drop Over SwedenBoeing B-52 Stratofortress bombers were deployed to conduct a low-pass flyover in Sweden. The flight marked the anniversary ...
Emergent BioSolutions Inc. (NYSE:EBS) Q4 2024 Earnings Call Transcript ... Inc. may make projections and other forward-looking statements related to their business, future events, their prospects ...
A payroll tax liability-responsibility shift from umbrellas to agencies dangerously throws the baby out with the bathwater. It must be stopped.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback